钙藻酸盐敷料在经皮腔内血管成形术后血管通路止血中的随机对照试验
本研究纳入200例接受PTA的血液透析患者,随机分为钙藻酸盐敷料组和无药物洗脱敷料对照组,评估穿刺点止血效果。结果显示钙藻酸盐组5分钟止血率显著更高(57% vs 39%,P=0.01),且使用钙藻酸盐敷料是5分钟内止血的独立促进因素(OR 2.33)。结论认为钙藻酸盐敷料可安全缩短PTA后止血时间,尤其适用于出血倾向患者。
要点
- 钙藻酸盐敷料组5分钟止血率57%,显著高于对照组的39%(P=0.01)。
- 使用钙藻酸盐敷料与5分钟内止血独立相关(OR 2.33,95%CI 1.26-4.37)。
- 血小板计数≤100 000/μL、每日抗血栓药≥1片及上臂血管通路则降低5分钟内止血几率。
核心结论
- 钙藻酸盐敷料可安全缩短PTA后穿刺点止血时间,应考虑用于出血倾向患者。
研究设计与样本
- 随机对照试验,纳入200例接受PTA的血液透析患者,钙藻酸盐组(n=100)与无药物洗脱敷料对照组(n=100)。
主要发现
- 钙藻酸盐组5、10、15及>15分钟止血率分别为57%、25%、8%、10%,对照组分别为39%、28%、14%、19%。
- 5分钟止血率组间差异显著(P=0.01),钙藻酸盐组更高。
- 多因素logistic回归显示,使用钙藻酸盐敷料与5分钟内止血独立相关(OR 2.33;95%CI 1.26-4.37)。
- 血小板计数≤100 000/μL(OR 0.19;95%CI 0.04-0.69)、每日抗血栓药≥1片(OR 0.50;95%CI 0.26-0.94)及上臂血管通路(OR 0.16;95%CI 0.03-0.55)与5分钟内止血几率降低独立相关。
临床怎么用
- 对于接受PTA的血液透析患者,可考虑使用钙藻酸盐敷料以缩短穿刺点止血时间。
- 对存在出血倾向(如血小板计数≤100 000/μL或使用抗血栓药物)的患者,钙藻酸盐敷料可能尤其有益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Management of vascular access (VA) is essential in hemodialysis (HD) patients. However, VA often fails and percutaneous transluminal angioplasty (PTA) is required. Conventional hemostasis at the puncture site is associated with complications. This study aimed to analyze the efficacy and safety of a hemostatic wound dressing made of calcium alginate at the puncture site of VA after PTA and evaluate other factors affecting hemostasis. METHODS: After PTA for VA, 200 HD patients were randomized to a calcium alginate sheet (CA) group (n = 100) or a no drug-eluting sheet (control) group (n = 100). We recorded time to hemostasis at the puncture site every 5 min, noting any complications. RESULTS: In the CA group, rates of hemostatic achievement at 5, 10, 15 and >15 min were 57, 25, 8 and 10%, respectively. In the control group, the rates were 39, 28, 14 and 19%, respectively. Rates of hemostatic achievement at 5 min were significantly higher in the CA group (P = 0.01). In logistic regression analysis, factors affecting hemostasis within 5 min were use of the CA sheet [odds ratio (OR) 2.33; 95% confidence interval (CI) 1.26-4.37], platelet count ≤100 000/μL (OR 0.19; 95% CI 0.04-0.69), number of antithrombotic tablets used per day ≥1 tablet (OR 0.50; 95% CI 0.26-0.94) and upper arm VA (OR 0.16; 95% CI 0.03-0.55). CONCLUSIONS: A CA sheet can safely reduce time to hemostasis at the puncture site after PTA, and should be considered for treating patients with a bleeding tendency.
引用
- Matsubara M, Banshodani M, Takahashi A, et al. Vascular access management after percutaneous transluminal angioplasty using a calcium alginate sheet: a randomized controlled trial. Nephrol Dial Transplant. 2019. PMID: 29846686. doi:10.1093/ndt/gfy143
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。